BMY News

Latest breaking news and updates for BMY stock.

Track all markets on TradingView

Bristol Myers Squibb to Present New Clinical and Real-World Data at the European Society of Cardiology Congress 2025

PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Camzyos--Bristol Myers Squibb to Present New Clinical and Real-World Data at the European Society of Cardiology Congress 2025

What are the regulatory and reimbursement expectations following the ESC 2025 presentation, and how could they affect long‑term revenue forecasts? What competitive advantage could the new data provide BMY against other cardiovascular drug manufacturers? How might the presented clinical and real‑world data influence BMY's stock price in the short term?
Clinical trials
about 2 hours ago
Read more businesswire

Bristol Myers Squibb’s Application for Breyanzi (lisocabtagene maraleucel) Accepted for Priority Review by U.S. Food and Drug Administration (FDA) in Fifth Cancer Type for Relapsed or Refractory Marginal Zone Lymphoma (MZL)

PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Breyanzi--Bristol Myers Squibb’s Application for Breyanzi Accepted by U.S. FDA in Fifth Cancer Type for Relapsed or Refractory Marginal Zone Lymphoma (MZL)

What are the implications for the company's pipeline valuation and overall R&D spending expectations? How might the acceptance for priority review affect the licensing and partnership dynamics with biotech collaborators? Could this news trigger short‑term trading opportunities or options strategies around the stock?
Regulatory
21 days ago
Read more businesswire